Foundations for Directed Alkaloid Biosynthesis  by Bachmann, Brian O.
Chemistry & Biology
PreviewsFoundations for Directed Alkaloid Biosynthesis
Brian O. Bachmann1,*
1Department of Chemistry, Vanderbilt University, 7921 Stevenson Center, Nashville, TN 37235, USA
*Correspondence: brian.bachmann@vanderbilt.edu
DOI 10.1016/j.chembiol.2007.08.001
In this issue of Chemistry & Biology, Bernhardt and coworkers [1] assay the functional plasticity
of strictosidine synthase, a gateway enzyme in the biosynthetic pathways of monoterpene indole
alklaloids, and the downstream operability of the products of strictosidine synthase variants in the
larger context of the plant biosynthetic pathways.Over the past half century, dissecting
the choreographies of natural product
biosynthetic pathways has resulted in
a greater understanding of the strat-
egies that living systems employ in
constructing structurally complex bio-
logically active molecules. However,
almost since the inception of the field
of natural product biosynthetic stud-
ies, researchers have provided addi-
tional justifications for their endeavors.
Often, in the concluding sentences of
research articles or terminal aims of
grant applications, there are allusions
to themore ‘‘translational’’ goals of ap-
plying the biological systems under
consideration for the synthesis and/or
discovery of novel chemical entities.
But despite decades in pursuit of these
ambitious goals, comparatively little
progress has been made in this practi-
cal area.
It can be speculated that the rea-
sons for the slow growth of this disci-
pline are primarily practical in nature.
As the chemical basis for enzyme
catalysis and protein folding are still
a matter of some debate, enzymes
often remain intransigent with regard
to coaxing them to utilize a specific
substrate. Furthermore, in vivo appli-
cation of enzymes in the context of
new biosynthetic pathways is also
fraught with complications such as
metabolite transport, toxicity, regula-
tion, and up/downstream pathway
flexibility. Finally, the skill set that is
required to successfully prosecute an
engineered pathway often includes
skills in chemical synthesis for prepa-
ration of substrates and intermediates
in addition to familiarity with advanced
molecular biology methodology and
biochemical principles. Despite these
intimidating barriers, a generation ofresearchers is emerging that is
increasingly interested in the trans-
lational or ‘‘synthetic biology’’ appli-
cations of the knowledge base in
biosynthetic studies. Interestingly,
two general strategies, distinct in their
aims and approaches, are emerging
that describe the efforts in this area.
One strategy might be characterized
as ‘‘target-based’’ and the other as
‘‘function-based’’ engineering.
In target-based engineering en-
deavors, the mission is to catalyze
the formation of a specific molecular
entity by engineering new enzymes
and/or biosynthetic pathways from
existing pathways. These efforts face
all of the aforementioned challenges
with regard tomodifying enzyme spec-
ificity and subsequent in vivo compli-
cations. However, recent successes
in these areas are accumulating and
examples can be found in directed bio-
synthesis of new terpenes [2], peptides
[3, 4] and polyketides [5]. A general dis-
advantage of this approach is that if
the enzyme/pathway proves intransi-
gent to modification, the researcher is
left with little to show for his or her en-
deavors at the end of the day. But if
successful, the technical accomplish-
ment of bending a natural system
toward an unnatural aim is impressive
and insights into enzyme function and
evolution are often gained in the
process.
In function-based engineering ef-
forts, biosynthetic enzymes and path-
ways aremodified, either using a struc-
ture-based approach, by random
mutagenesis or by some combination
of these methods, followed by screen-
ing for new reaction products. Suc-
cessful examples of this strategy
have appeared in terpenoid biosynthe-Chemistry & Biology 14, August 2007 ªsis [6] and P450 hydroxylation [7]
areas, among others. A distinct ad-
vantage of nontargeted engineering is
that instead of becoming hamstrung
on a specific molecular target, a re-
searcher navigates the functional
landscape of biochemical actuality
rather than attempts to force a sys-
tem into a specific activity beyond its
scope. This strategy is akin to working
with an enzyme rather than against it.
A new example of successful func-
tion-based engineering is described
in this issue of Chemistry & Biology in
which Bernhardt and colleagues re-
cruit alkaloid biosynthetic biochemis-
try for the production of new indole
alkaloid compounds [1].
Strictosidine synthase catalyzes the
formation of strictosidine via an enzy-
matic version of the venerable Pictet-
Spengler reaction. Strictosidine is the
core metabolite leading to the mono-
terpene indole alkaloids in plants and
serves as a precursor for a great variety
of natural productswith significant bio-
logical activity and clinical relevance
including quinine (antimalarial), camp-
tothecin (anticancer, topoisomerase I),
and reserpine (antipsychotic, antihy-
pertensive), to name just a few.
Recently the structure of R. serpen-
tina strictosidine synthase was eluci-
dated, revealing it to be a pseudo-
symmetric six bladed b propeller with
the active site situated at the core of
the pseudosymmetry axis [8]. To mod-
ulate the substrate selectivity of the
related enzyme from Catharansus
roseus (periwinkle) Bernhardt and co-
workers target corresponding hydro-
phobic residues lining the tryptamine
binding site for saturationmutagenesis
and assay turnover for selected ana-
logs with a creative enzyme-coupled2007 Elsevier Ltd All rights reserved 875
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Previewshigh-throughput screen (Figure 1). This
work, which primarily explores the bio-
synthetic plasticity of the tryptamine
binding region, is highly complemen-
tary to recent studies from the O’Con-
nor laboratory regarding the muta-
tional plasticity of the secologanin
binding site [9] and the substrate flexi-
bility of the wild-type enzyme [10].
An open question is how will func-
tion-based efforts converge with prac-
tical goals of synthetic biology and
drug discovery? A unique feature of
this study and its secologanin com-
panion is the consideration of the
downstream consequences of early
precursor modification. Ostensibly, as
the number of downstream steps in-
creases, the number of binding sites
the substrates must negotiate in-
creases and the chances for travers-
ing a pathway decreases. However,
Bernhardt et al. [1] have been able to
demonstrate a good degree of path-
way operability downstream and the
formation of several new products
was observed. One of these new com-
pounds was isolated and the structure
Figure 1. Directed Biosynthesis of Indole Alkaloids via Strictosidine Synthase
Residues highlighted in green were selected for saturation mutagenesis to modify substrate
selectivity.876 Chemistry & Biology 14, August 2007 ª2007 Elsevier Ltd All rights reserveddetermined to be a novel isositsirikine
analog. This demonstration of down-
stream pathway flexibility lays the
groundwork for the diversification of
alkaloid biosynthesis by pathway
engineering.
With regard to the complementary
modes of target-based and function-
based directed biosynthesis, the dis-
tinction may be somewhat artificial
for the distinction is really a matter of
actuality versus intent. Indeed, since
we don’t know the full spectrum of
failed experiments in target-based en-
gineering efforts, it is possible that
these studies resemble their function-
based relatives more than the external
observer might initially assume.
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